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Background
Impaired eye movements and other disorders of the visual
system, such as diplopia and ptosis of the eyelid are
among the most common clinical manifestations of
myasthenia gravis (MG), while the disorders of pupil size
and papillary dysfunction are less well-known and has
never been fully resolved. Glaser (1981) and David A.
(2002) categorically stated that the pupils are unaffected
whereas Wilson (1940) and Walton (1977) indicate that
the pupils may be sluggish or exhibit fatigability. One of
the most interesting features of the eye is the pupil's reac-
tion to light. The pupil serves as a gain-control device for
the visual system. It responds to luminance changes in the
environment, and this response is largely governed by a
well-characterized subcortical projection through the pre-
tectum to the accessory oculomotor nucleus (Lowenfeld
1993). The purpose of this study was to measure the pupil
reaction to light by using a new technologically infrared
video pupillometer in subjects with a newly diagnosed
myasthenia gravis.
Material and Methods
Twenty eight patients and twenty controls were studied.
All patients (18 females and 10 males) with a ranging
between 22 and 65 years were free of any other neurolog-
ical or ophthalmological disease. In order to study the
pupil reaction to light (velocity, acceleration and other
parameters), a new system was developed in the clinical
neurophysiology laboratory in collaboration with the
fluid mechanics section of the Aristotle University of Thes-
saloniki. This system of pupillometry consists of: 1) an
infrared camera of 260 frames per second 2) an SLE lamp
3) an infrared spot light 4) a head mounting device.
With central control from a P/C and fully automatised the
system consists of a digital camera with recording ability
of 260 frames per second (a simple non-digital camera
gets 25 frames per second). This high recording ability
allows precise calculations of this minute velocity, acceler-
ation and other parameters while simultaneously a fully
statistical analysis is being processed by using the sum-
ming average of all the recordings.
Results
Statistically important differences were observed between
two groups in relation to the maximum velocity and max-
imum acceleration to mysis, while the pupil reaction time
for mysis was clearly delayed in the group of the
myasthenic patients. Statistically important differences
were observed and after the treatment with pyridostig-
mine.
Discussion
The results of this study suggest that patients with
myasthenia gravis demonstrated diminished amplitude,
velocity, acceleration and other parameters. The strict
selection criteria of newly diagnosed MG patients free of
any neurological or ophthalmological disease, with best
corrected visual acuity of 20/20, and showing a good
response to pyridostigmine treatment, excludes the possi-
bility that other factors could have produced the differ-
ences in pupil reaction to light between patients and
normal subjects. In conclusion, from the above results it
seems that pupillometry is an easy to use non invasive
method that contributes to the early diagnosis of
myasthenia gravis while it can give us information for the
therapeutic outcome.
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